Neogen Chemicals Ltd. Managing Director Harin Kanani expressed confidence in maintaining margin of 17% to 18%. He added that the long-term target, driven by innovation, is to move closer to 20% and beyond. For FY27, this could translate to an Ebitda of "Rs 170, Rs 180 crore or slightly higher" from the main business, up from the Rs 130-crore-plus expected in FY26.